CD24 and medulloblastoma: Co-labelling with CD15 and CD24 allowed for the identification of a more mitotic and tumorigenic CD15+/CD24+ cell population within Ptch1 deleted medulloblastoma, illustrating that the CD24 TIC population could be further purified with CD15.